Hospital Corporation of China Limited (HCCL) was incorporated in 2014 and listed on the main board of the Hong Kong Stock Exchange (stock code 3869.HK) in 2017. It is a platform that integrates investment and operations in the medical service sector. Through mergers and acquisitions of hospitals that meet leading standards, HCCL implements operational management and control that complement the characteristics of the Chinese medical service industry, improves hospital capabilities and service standards, and continuously enhances the comprehensive value of its hospitals. A pioneer in the innovation of business models and optimization of business structures, the corporation is committed to transforming itself from a traditional chain of hospitals into a large-scale medical service and technology group that is trustworthy, respectable and excellence-centric.
HCCL has professional teams in the areas of medical investment, management, and operations. The hospitals it owns, manages, and operates include Shanghai Yangsi Hospital, Zhejiang Jinhua Guangfu Tumor Hospital, Yongkang Hospital, Jiande Traditional Chinese Medicine Hospital and Cixi Honghe Hospital, with over 3,000 beds and around 3,200 employees in total.